One important mechanism was revealed in a study that CD8+ T cells could disrupt AML progression caused by mutation of nucleophosmin 1 (NPM1) or FMS-like tyrosine kinase receptor 3 internal tandem duplication (FLT3-ITD) (13, 14). The gene discussed is NPM1; the disease is acute myeloid leukemia.